An Open-Label, Expanded Access Protocol for Boys with Duchenne Muscular Dystrophy who Have Completed the Long-Term Extension (VBP15-LTE) or VBP15-004 Studies

Project: Research project

Project Details

StatusActive
Effective start/end date1/8/208/31/50

Funding

  • Reveragen Biopharma, Inc.
  • Reveragen Biopharma, Inc.